Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats
- PMID: 14504685
- DOI: 10.1007/s00210-003-0800-x
Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats
Abstract
This study examined the effect of intrathecal (i.t.) injection of the endocannabinoid anandamide in urethane-anesthetized rats. The tip of the i.t. cannula was positioned at the T(12)-L(1) level of the spinal cord. Either anandamide or its metabolically stable analogue methanandamide (25 to 100 nmol) produced dose-dependent decreases in the blood pressure that persisted at least for up to 30 min. The hypotensive responses to 100 nmol anandamide and to 100 nmol methanandamide were -17.7+/-1.6 mmHg ( n=5) and -17.9+/-2.0 mmHg ( n=4), respectively. Hypotensive effects were also obtained with the CB(1) cannabinoid receptor agonist WIN 55212-2 (20 nmol; i.t.) as well as with the vanilloid VR(1) receptor agonist capsaicin (3 nmol; i.t.). Nicotinic ganglionic blockade with hexamethonium bromide [10 mg/kg; intravenous(i.v.)] abolished the responses to both anandamide and capsaicin. The i.t. administration of the CB(1) receptor antagonist, 20 nmol SR 141716A, as well as the VR(1) receptor antagonist, 20 nmol capsazepine, prevented almost completely the hypotensive responses to both anandamide and methanandamide. SR 141716A prevented the hypotension caused by WIN 55212-2 but did not modify the response to the vanilloid receptor agonist capsaicin. On the contrary, capsazepine antagonized the hypotension caused by capsaicin but failed to affect the decrease in blood pressure caused by the CB1 cannabinoid receptor agonist WIN 55212-2. These results suggest that anandamide could modulate the blood pressure through the activation of cannabinoid CB(1) receptors and vanilloid VR(1) receptors localized at the spinal cord.
Similar articles
-
Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.Naunyn Schmiedebergs Arch Pharmacol. 2001 Dec;364(6):562-9. doi: 10.1007/s00210-001-0498-6. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11770012
-
Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats.Eur J Pharmacol. 2006 Feb 17;532(1-2):88-98. doi: 10.1016/j.ejphar.2005.12.074. Epub 2006 Feb 10. Eur J Pharmacol. 2006. PMID: 16472800
-
Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide.Eur J Pharmacol. 2009 May 21;610(1-3):75-80. doi: 10.1016/j.ejphar.2009.03.021. Epub 2009 Mar 14. Eur J Pharmacol. 2009. PMID: 19289116
-
Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.Chem Phys Lipids. 2002 Dec 31;121(1-2):57-63. doi: 10.1016/s0009-3084(02)00146-9. Chem Phys Lipids. 2002. PMID: 12505690 Review.
-
New dawn of cannabinoid pharmacology.Trends Pharmacol Sci. 1994 Feb;15(2):40-1. doi: 10.1016/0165-6147(94)90106-6. Trends Pharmacol Sci. 1994. PMID: 8165721 Review. No abstract available.
Cited by
-
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.Br J Pharmacol. 2007 Jun;151(4):427-40. doi: 10.1038/sj.bjp.0707261. Epub 2007 Apr 23. Br J Pharmacol. 2007. PMID: 17450170 Free PMC article.
-
A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats.Br J Pharmacol. 2010 Jun;160(3):574-84. doi: 10.1111/j.1476-5381.2009.00579.x. Epub 2010 Jan 25. Br J Pharmacol. 2010. PMID: 20105178 Free PMC article.
-
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism.Br J Pharmacol. 2005 Nov;146(6):809-16. doi: 10.1038/sj.bjp.0706391. Br J Pharmacol. 2005. PMID: 16158067 Free PMC article.
-
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?Br J Pharmacol. 2012 Apr;165(7):2073-88. doi: 10.1111/j.1476-5381.2011.01747.x. Br J Pharmacol. 2012. PMID: 22022923 Free PMC article. Review.
-
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):345-69. doi: 10.1007/s00210-008-0327-2. Epub 2008 Jul 25. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18654765 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous